← Solvonis Therapeutics
What podcasts say about Solvonis Therapeutics
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Solvonis Therapeutics
5 statements · 5 positive
Solvonis researchers discovered a molecule combining targeted antidepressant pharmacologies.
“we've discovered in our research a molecule that fits that particular criteria.”
Open the episode · S12 Ep6: Sunday Roast - Mantle Resilience Plc,Xtract Resources,Bezant Resources,Solvonis Therapeutics plc, African Pioneer, Kendrick Resources, Active Energy Group PLC, Critical Mineral Resources & Galileo Resources #MNTL #XTR #BZT #SVNS #AFP #KEN #AEG #CMRS #GLRListen at 1:02:04
Solvonis’s molecule is designed to improve enjoyment while reducing SSRI-related adverse effects.
“It'll promote mood and what we call hedonic tone and enjoyment, but also offset any of the unwanted negative effects of the SSRIs.”
Open the episode · S12 Ep6: Sunday Roast - Mantle Resilience Plc,Xtract Resources,Bezant Resources,Solvonis Therapeutics plc, African Pioneer, Kendrick Resources, Active Energy Group PLC, Critical Mineral Resources & Galileo Resources #MNTL #XTR #BZT #SVNS #AFP #KEN #AEG #CMRS #GLRListen at 1:04:09
Tennyson believes Solvonis has a very good business and plan.
“We are, we have a, what I believe to be a very good business. with a very good plan.”
Open the episode · S11 Ep100: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNSListen at 14:05
Solvonis’s team should execute, create value and communicate progress.
“What I and the team now need to do is put our head down and execute, create value and communicate that to the street”
Open the episode · S11 Ep100: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNSListen at 14:24
Solvonis should use raised capital prudently to execute and communicate potential value creation.
“We need to use that capital judiciously. to execute the business plan and to communicate out to investors so that current investors and potential new investors understand the value that we have the potential to create.”
Open the episode · S11 Ep100: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNSListen at 15:33
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.